FDAnews
www.fdanews.com/articles/75216-velcura-therapeutics-r-inc-and-nippon-chemiphar-co-ltd-announce-agreement-to-develop-new-drug

VELCURA THERAPEUTICS(R), INC. AND NIPPON CHEMIPHAR, CO., LTD. ANNOUNCE AGREEMENT TO DEVELOP NEW DRUG

August 10, 2005

U.S. biotechnology company Velcura Therapeutics®, Inc. announced a license agreement with Nippon Chemiphar Co. (Chemiphar), Ltd., a Japanese pharmaceutical company listed on the Tokyo Stock Exchange. The license agreement enables the two companies to further develop new small-molecule therapies for osteoporosis and other bone diseases. This is a critical unmet need, as osteoporosis is second only to cardiovascular disease as a world health problem, according to the World Health Organization.

Yahoo News (http://biz.yahoo.com/prnews/050809/detu007.html?.v=21)